Concepedia

Publication | Closed Access

Effects of 24-week Toll-like receptor 9 agonist treatment in HIV type 1+ individuals

DOI

88

Citations

41

References

2019

Year

Line K. Vibholm, Christina Valbirk Konrad, Mariane Høgsbjerg Schleimann, Giacomo S. Frattari, Anni Winckelmann, Vibeke Klastrup, Nanna Møller Jensen, Sanne Jensen, Manuel Schmidt, Burghardt Wittig,
AIDS

Abstract

TLR9 Enhancement of antiviral immunity in chronic HIV-1 infection: a phase 1B/2A trial; ClinicalTrials.gov NCT02443935.

References

YearCitations

Page 1